CCIA
BMY icon

Cherry Creek Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Cherry Creek Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$562K Buy
9,754
+84
+0.9% +$4.82K 0.22% 69
2026
Q1 		$587K Buy
9,670
+67
+0.7% +$3.91K 0.25% 59
2025
Q4 		$518K Buy
9,603
+79
+0.8% +$3.8K 0.22% 66
2025
Q3 		$430K Sell
9,524
-923
-9% -$43.1K 0.19% 73
2025
Q2 		$484K Buy
10,447
+84
+0.8% +$4.12K 0.23% 65
2025
Q1 		$632K Buy
10,363
+97
+0.9% +$5.65K 0.33% 52
2024
Q4 		$581K Buy
10,266
+101
+1% +$5.64K 0.29% 52
2024
Q3 		$526K Buy
10,165
+183
+2% +$8.59K 0.27% 55
2024
Q2 		$415K Sell
9,982
-347
-3% -$15.5K 0.22% 69
2024
Q1 		$560K Sell
10,329
-14,872
-59% -$758K 0.3% 54
2023
Q4 		$1.29M Sell
25,201
-1,890
-7% -$99.2K 0.79% 30
2023
Q3 		$1.57M Sell
27,091
-1,183
-4% -$72.5K 1.07% 23
2023
Q2 		$1.81M Buy
28,274
+166
+0.6% +$11.1K 1.22% 21
2023
Q1 		$1.95M Buy
28,108
+210
+0.8% +$14.8K 1.43% 19
2022
Q4 		$2.01M Buy
27,898
+414
+2% +$31.2K 1.56% 18
2022
Q3 		$1.95M Buy
27,484
+189
+0.7% +$13.7K 1.62% 16
2022
Q2 		$2.1M Buy
27,295
+137
+0.5% +$10.4K 1.7% 17
2022
Q1 		$1.98M Buy
27,158
+315
+1% +$21.1K 1.31% 22
2021
Q4 		$1.67M Buy
26,843
+557
+2% +$32.7K 1.04% 29
2021
Q3 		$1.55M Sell
26,286
-405
-2% -$26.7K 1.04% 31
2021
Q2 		$1.78M Buy
+26,691
New +$1.74M 1.17% 26

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cherry Creek Investment Advisors's BMY Position: Q2 2026 in Review

Cherry Creek Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.87% in Q2 2026, buying an estimated $4.82K and bringing the position to 9,754 shares worth $562K. The position accounts for 0.22% of the portfolio, ranked #69.

Cherry Creek Investment Advisors first reported a position in BMY in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.1M in Q2 2022. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Cherry Creek Investment Advisors held 9,754 shares of Bristol-Myers Squibb worth $562K as of Q2 2026.
  • Cherry Creek Investment Advisors bought 84 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.82K.
  • Bristol-Myers Squibb made up 0.22% of Cherry Creek Investment Advisors's portfolio in Q2 2026, its #69 holding.
  • Cherry Creek Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 21 quarters since.
  • Cherry Creek Investment Advisors's Bristol-Myers Squibb position peaked at $2.1M in Q2 2022.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cherry Creek Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.